Phosphorylcholine coating of bypass systems used for young infants does not attenuate the inflammatory response

Annals of Thoracic Surgery

Volumn 81, Issue 4, 2006, Pages 1455-1459

  Draaisma, Anjo M ^a   Hazekamp, Mark G ^b   Anes, Nanning ^b   Schoof, Paul H ^b   Hack, C Erik ^b   Sturk, Augueste ^b   Dion, Robert A E ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3B; INTERLEUKIN 6; LEUKOCYTE ELASTASE; PHOSPHORYLCHOLINE;

ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONGENITAL HEART MALFORMATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYANOSIS; DOWN SYNDROME; FEMALE; HUMAN; INFANT; INFLAMMATION; INTENSIVE CARE; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REOPERATION;

CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; DOUBLE-BLIND METHOD; EQUIPMENT DESIGN; FEMALE; HUMANS; INFANT; INFLAMMATION; MALE; PHOSPHORYLCHOLINE; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 33645343019     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.11.058     Document Type: Article

References (22)

1. M.C. Seghaye, J. Duchateau, R.G. Grabitz, G. Nitsch, C. Marcus, B.J. Messmer Complement, leokocytes, and leukocytes elastase in ful-term neoanates undergoing cardic operations J Thorac Cardiovasc Surg 108 1994 29 36
2. J.K. Kirklin, S. Westaby, E.H. Blackstone, J.W. Kirklin, D.E. Chenoweth, A.D. Pacifico Complement and the damaging effects of cardiopulmonary bypass J Thorac Cardiovasc Surg 86 1983 845 857
3. J. Yu, N.M.K. Lamba, J.M. Courtney Polymeric biomaterials influence of phosphorylcholine polar groups on protein adsorption and complement activation Int J Artif Organs 17 1994 499 504
4. R.F. Zwaal, H.C. Hemker Blood cell membranes and haemostasis Haemostasis 11 1982 12 39
5. G.J. Hauser, J. Ben-Ari, M.P. Colvin Interleukin-6 levels in serum and lung lavage fluid in children undergoing open heart surgery correleted with postoperative morbidity Intens Care Med 24; 1998 481 486
6. G.J. Wolbink, M.C. Brouwer, S. Buysmann, I.J. ten Berge, C.E. Hack CRP-mediated activation of complement in vivo assessment by measuring circulating complement-C-reactive protein complexes J Immunol 157 1996 473 479
7. F. DeSomer, K. Francois, J. Poelaert, D. De Wolf, T. Ebels, G. Van Nooten Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface Eur J Cardiothoracic Surg 18 2000 602 606
8. A. Böning, J. Scheewe, T. Ivers Phosphorylcholine coating or heparin coating for pediatric extracorpereal circulation causes similar effects in neonates and infants J Thorac Cardiovasc Surg 127 2004 1458 1465
9. S.B. Horten, W.W. Butt, R.J. Mullaly Il-6 and Il-8 levels after cardiopulmonary bypass are not affected by surface coating Ann Thorac Surg 68 1999 1751 1755
10. A. Tárnok, J. Hambsch, F. Emmrich Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass Pediatr Cardiol 20 1999 113 125
11. P. Biglioli, A. Cannata, F. Alamanni Biological effects of off-pump vs. on-pump coronary artery surgery focus on inflammation, hemostasis and oxidative stress Eur J Cardiothorac Surg 24 2003 260 269
12. R. Prondzinsky, A. Knüpfer, H. Loppnow Surgical trauma affects the proinflammatory status after cardiac surgery to a higher degree than cardiopulmonary bypass J Thorac Cardiovasc Surg 129 2005 760 766
13. R. Ascione, C.T. Lloyd, M.J. Underwood, A.A. Lotto, A.A. Pitsis, G.D. Angelini Inflammatory response after coronary revascularization with or without cardiopulmonary bypass Ann Thorac Surg 69 2000 1198 1204
14. G.J. Murphy, G.D. Angelini Side effects of cardiopulmonary bypass what is the reality? J Card Surg 19 2004 481 488
15. M. Westerberg, A. Bengtsson, A. Jeppsson Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Ann Thorac Surg 78 2004 54 59
16. S. Ghosh, M.J. May, E.B. Kopp NF-κB and REL proteins evolutionarily conserved mediators of immune responses Annu Rev Immunol 16 1998 225 260
17. F. Licastro, C. Melotti, R. Parente Derangement of non-specific immunity in Down syndrome subjects low leukocyte chemiluminescence activity after phagocytic activation Am J Med Genet 7 Suppl 1990 242 246
18. A.G. Ugazio, R. Maccario, L.D. Notarangelo, G.R. Burgio Immunology of Down syndrome a review Am J Med Genet 7 Suppl 1990 204 212
19. A.F. Corno, G. Milano, M. Samaja, P. Tozzi, L.K. von Segesser Chronic hypoxia a model for cyanotic congenital heart defects J Thorac Cardiovasc Surg 124 2002 105 112
20. M. Qing, J.F. Vazquez-Jimenez, B. Klosterhalfen Influence of temperature during cardiopulmonary bypass on leukocyte activation, cytokine balance, and post-operative organ damage Shock 15 2001 372 377
21. B. Wolach, T. Dolfin, R. Regev, S. Gilboa, M. Schlesinger The development of the complement system after 28 weeks' gestation Acta Paediatr 86 1997 523 527
22. M. Haeney Infection determinants at extremes of age J Antimicrob Chemother 34 Suppl 1994 A1 A9